发明名称 1,1- AND 1,2-DISUBSTITUTED CYCLOPROPANE COMPOUNDS.
摘要 A compound selected from those of formula (I): wherein: p represents an integer of from 0 to 6 inclusive, n represents an integer of from 0 to 6 inclusive, R1, and R2 represent a group selected from hydrogen, alkyl, aryl and arylalkyl, or R1+R2 form together with nitrogen carrying them saturated, monocyclic, or bicyclic system, X represents a group selected from oxygen, sulphur, a group -CH=CH-, methylene, a group of formula -HC=N-O- and a group of formula -O-CH2-CH=CH-, in which groups oxygen is linked to Y of the compounds of formula (I), Y represents a group selected from aryl, heteroaryl, arylalkyl, heteroarylalkyl, -C(O)-A, and -C(S)-A, A represents a group selected from alkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl, and NR3R4 wherein R3, and R4 represent a group selected from hydrogen, alkyl, aryl, and arylalkyl, or R3+R4 form together with nitrogen carrying them monocyclic, or bicyclic (C3-C10) system, its isomers and addition salts thereof with a pharmaceutically-accepta ble acid or base, and medicinal products containing the same are useful as specific nicotinic ligand of (alpha4beta2 receptors).
申请公布号 MXPA01006586(A) 申请公布日期 2002.03.20
申请号 MX2001PA06586 申请日期 2001.06.26
申请人 LES LABORATOIRES SERVIER. 发明人 PIERRE LESTAGE.
分类号 C07D295/08;A61K31/10;A61K31/13;A61K31/133;A61K31/15;A61K31/16;A61K31/215;A61K31/22;A61K31/221;A61K31/223;A61K31/27;A61K31/40;A61K31/44;A61K31/4402;A61K31/4406;A61K31/445;A61K31/455;A61P25/00;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P25/34;A61P29/00;A61P29/02;A61P43/00;C07C62/02;C07C209/00;C07C211/37;C07C213/00;C07C213/02;C07C213/06;C07C215/20;C07C215/42;C07C217/44;C07C217/52;C07C219/18;C07C219/20;C07C219/24;C07C269/00;C07C269/02;C07C271/12;C07C271/22;C07C271/24;C07C271/34;C07C319/14;C07C321/28;C07C323/26;C07C323/33;C07D213/30;C07D213/38;C07D213/53;C07D213/65;C07D213/70;C07D213/80;C07D213/803;C07D295/096;C07D417/12;(IPC1-7):A61K31/13;A61K31/396;A61K31/397;C07D211/08 主分类号 C07D295/08
代理机构 代理人
主权项
地址